Trial Profile
A Randomized, Double-blind, Active Controlled, Multi-center, Phase 1 Study to Investigate the Safety of MEDITOXIN® in Female Subjects With Idiopathic Overactive Bladder
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Medytox
- 25 Mar 2019 Status changed from recruiting to completed.
- 22 Dec 2017 New trial record